A multi-centre, prospective, observational study for real-world treatment of hyperkalaemia among patients in emergency department of China

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100053100

Enrollment

Unknown

Registered

2021-11-10

Start date

2022-01-31

Completion date

Unknown

Last updated

2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalaemia

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >18 years; 2.Emergency department visits; 3.The serum potassium value detected in emergency department was >=5.5 mmol/L; 4.Signed ICF.

Exclusion criteria

Exclusion criteria: 1.Previously included in this study; 2.Participating in another clinical research (e.g., an investigational agent) could impact this study within the last 3 months of enrolment day. 3.Patients deemed unsuitable for inclusion in the study according to the investigator's judgment.

Design outcomes

Primary

Measure	Time frame
Mean amplitude of change in serum potassium levels from baseline to 5±1 h;	—

Secondary

Measure	Time frame
Baseline blood potassium level;Proportion of patients;Average number of blood potassium tests;The time interval between the first and second blood potassium tests;Time from blood potassium test report to initiation of potassium lowering therapy;	—

Countries

China

Contacts

Public ContactYu Xuezhong

Peking Union Medical College Hospital

yxz@pumch.cn+86 13601262164

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 20, 2026